Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Inappropriate Therapies and Serious Adverse Cardiac and Cerebrovascular Events With a Single Chamber Implantable Cardioverter Defibrillator (ICD) With DX Floating Dipole Detection. PREVENT DX

NCT04344704 is registered in ClinicalTrials.gov with Trialance SCCL as lead sponsor.

NCT NCT04344704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04344704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Inappropriate Therapies and Serious Adverse Cardiac and Cerebrovascular Events With a Single Chamber Implantable Cardioverter Defibrillator (ICD) With DX Floating Dipole Detection. PREVENT DX
Lead sponsor
Trialance SCCL
Phase
Observational
Overall status
Unknown status
Start date
November 2, 2018
Completion date
March 31, 2023
Enrollment
462 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

prevention of inappropriate therapies and macce. single-chamber icd